LiquiGlide Completes $13.5 Million Funding Round

LiquiGlide, inventors of a technology with potential to revolutionize products, packaging, processes and patient experiences by eliminating the friction between solids and liquids, has completed its latest $13.5M funding round and announced new partnerships with Colgate and the Mibelle Group. This brings the total amount raised to $50M and represents a strategic raise at a pivotal moment for the company.
 
Invented at MIT by co-founders Dave Smith and professor Kripa Varanasi, the company’s patented technology removes friction, allowing thick, slow-moving liquids to flow with ease. In 2012, the company debuted a popular video that showed a new world of possibilities in packaging and beyond. By eliminating friction, LiquiGlide has made previously impossible advancements in packaging, manufacturing, and medical devices a reality via safe and sustainable solutions that meet rigorous safety and regulatory standards.
 
“Our technology has redefined what’s possible when working with thick, slow-moving liquids,” said Dave Smith, co-founder and CEO at LiquiGlide. “We’re already seeing its impact with extraordinary breakthroughs in packaging, manufacturing, and the biomedical industry. As we continue to expand our market presence with our latest partnerships with Colgate and the Mibelle Group, we’re proud to join forces with global leaders in innovation and consumer goods.”
 
Partnership with Colgate
 
Consumers will soon be able to experience the difference LiquiGlide makes in the way they experience the products they use every day. For consumers in Europe, Colgate has just introduced a transformational, clear, PET, recyclable toothpaste package, developed in partnership with LiquiGlide, that allows toothpaste to dispense much more easily.
  
LiquiGlide’s benefits extend beyond consumer products. The company is also focused on critically important applications of its technology in the biomedical domain, including the prevention of clogging, reduction of device-related infection, and the enhanced production and delivery of viscous drugs and biologics.
 
These partnerships, along with rapidly increasing consumer demand for more sustainable goods, underscore the vast opportunity ahead for LiquiGlide. The company nearly doubled its team in 2020 as it prepares to expand its technology into more applications.
 
Expanding Leadership
 
As part of its growth, LiquiGlide added veteran executives from the packaging and biotech sectors. Damien Dossin will serve as executive vice president and general manager of its Consumer Packaged Goods Division and Dan Rippy joined as executive vice president and general manager of LiquiGlide’s Biomedical Division. The company also appointed Tom Britanik, formerly CMO of The Clorox Company with decades of experience in the consumer packaged goods industry, to the role of CMO at LiquiGlide.
 
“We are surrounded by liquid products – from food or cosmetics in everyday life to valuable drugs or biologics in industry. Until now, we’ve accepted significant waste, whether in manufacturing or in packaging, as part of the price for these products because they stick to containers or devices they touch,” said Professor Kripa Varanasi, co-founder and chairman of LiquiGlide. “By eliminating friction, LiquiGlide’s technology removes this basic constraint. Now, we can dispense every last drop, minimize yield loss in manufacturing, and reduce occlusions and infections in medical devices. Our team is on a mission to change the paradigm across industries to usher in sustainable products and processes as well as improve patient outcomes.”